Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Asthma

Free Subscription Articles published in Ann Allergy Asthma Immunol Retrieve available abstracts of 141 articles: HTML format

Single Articles

October 2025
1. LAIDLAW TM
   Aspirin-exacerbated respiratory disease in the era of biologics.
   Ann Allergy Asthma Immunol. 2025;135:366-373.
   PubMed     Abstract available
   
   
   September 2025
2. KUNG TJ, Weng CF, Wu SC, Lin FJ, et al
   Comparative Effectiveness of Fixed-Dose ICS/LABA Therapy in Adult Patients with Asthma.
   Ann Allergy Asthma Immunol. 2025 Sep 29:S1081-1206(25)01205.
   PubMed     Abstract available
   
   
   
3. THOMPSON D, Visness CM, Wood RA, O'Connor GT, et al
   Associations between body weight, asthma burden, and T2 inflammation among under-resourced children.
   Ann Allergy Asthma Immunol. 2025 Sep 27:S1081-1206(25)01204.
   PubMed     Abstract available
   
   
   
4. AMADO C, Lopez-Padilla D, Mendez R, Martinez-Garcia MA, et al
   AIRWAY OVERLAP SYNDROMES WITH ASTHMA.
   Ann Allergy Asthma Immunol. 2025 Sep 18:S1081-1206(25)01168.
   PubMed     Abstract available
   
   
   
5. TIOTIU A, Pilette C, Bagnasco D, Bondi B, et al
   Comparative analysis of biologics' effects on lung function parameters in severe asthma.
   Ann Allergy Asthma Immunol. 2025 Sep 6:S1081-1206(25)01156.
   PubMed     Abstract available
   
   
   
6. JHANG YS, Chang HC, Gau SY
   Risk of asthma in US adults with COVID-19 in real-world settings.
   Ann Allergy Asthma Immunol. 2025;135:347-348.
   PubMed    
   
   
   
7. ABDELKADER S, Voladri DR, Kennedy JL
   Beyond respiratory syncytial virus and rhinovirus: The other viral respiratory bandits.
   Ann Allergy Asthma Immunol. 2025;135:249-260.
   PubMed     Abstract available
   
   
   August 2025
8. PATERSON F, On JY, Ahmed D, Poto R, et al
   Real-life evaluation of novel forced expiratory ratios with asthma exacerbations and symptoms.
   Ann Allergy Asthma Immunol. 2025 Aug 29:S1081-1206(25)00440.
   PubMed     Abstract available
   
   
   
9. GHABOUSIAN A, Bezerra GN, Zhu Z, Espinola JA, et al
   Impact of varying childhood asthma definitions on incidence and clinical outcomes.
   Ann Allergy Asthma Immunol. 2025 Aug 14:S1081-1206(25)00414.
   PubMed     Abstract available
   
   
   
10. KHEZRIAN M, Kerkhof M, Le TT, Harrison T, et al
    Adherence to inhaled corticosteroid medications following an asthma exacerbation and the risk of subsequent exacerbations.
    Ann Allergy Asthma Immunol. 2025 Aug 13:S1081-1206(25)00416.
    PubMed     Abstract available
    
    
    July 2025
11. GALLETTA F, Passanisi S, Randazzese SF, Licari A, et al
    Real-Life Evaluation of Biologics in Pediatric Severe Asthma Using Core Outcome Measures for Severe Asthma.
    Ann Allergy Asthma Immunol. 2025 Jul 31:S1081-1206(25)00395.
    PubMed    
    
    
    
12. GREIG R, Chan R, Lipworth B
    Type 2 biomarkers and airway hyper-responsiveness disconnect in uncontrolled severe asthma patients taking benralizumab or dupilumab.
    Ann Allergy Asthma Immunol. 2025 Jul 26:S1081-1206(25)00379.
    PubMed    
    
    
    
13. CORONEL AC, Sanchez-Tamay NM, Ballena-Caicedo J, Zuzunaga-Montoya FE, et al
    Prevalence of asthma in adults in Latin America: a systematic review and meta-analysis.
    Ann Allergy Asthma Immunol. 2025 Jul 24:S1081-1206(25)00375.
    PubMed     Abstract available
    
    
    
14. ONGTENGCO A, Wilt E, Hardy P, Youssef C, et al
    "Getting in and doing it personally": Engagement Strategies for Rural School Asthma Programs.
    Ann Allergy Asthma Immunol. 2025 Jul 24:S1081-1206(25)00377.
    PubMed     Abstract available
    
    
    
15. MENDOZA LE, Casilang CG, Morphew T, Barrows J, et al
    Feasibility of Remote Patient Monitoring to Increase Inhaled Corticosteroid Adherence in Children with High-Risk Asthma.
    Ann Allergy Asthma Immunol. 2025 Jul 23:S1081-1206(25)00369.
    PubMed     Abstract available
    
    
    
16. CHIPPS BE, Panettieri RA Jr, Skolnik N, Cappelletti C, et al
    Albuterol-budesonide rescue inhaler for asthma: patterns of use and safety in the MANDALA trial.
    Ann Allergy Asthma Immunol. 2025 Jul 13:S1081-1206(25)00348.
    PubMed     Abstract available
    
    
    
17. BUSSE WW
    Oh Eosinophil, what can you tell us about asthma?
    Ann Allergy Asthma Immunol. 2025 Jul 10:S1081-1206(25)00347.
    PubMed     Abstract available
    
    
    
18. COTE A, Beach J, Reynolds J, Usuba K, et al
    ALERT (ChAracterizing uncontroLled sevERe asThma in Canada): oral corticosteroid and short-acting beta(2)-agonist overuse.
    Ann Allergy Asthma Immunol. 2025 Jul 10:S1081-1206(25)00346.
    PubMed     Abstract available
    
    
    
19. MAHMOOD LZ, Perry TT, Jefferson AA, Berlinski A, et al
    Implications of removing race from spirometry reference equations in children with asthma.
    Ann Allergy Asthma Immunol. 2025 Jul 10:S1081-1206(25)00343.
    PubMed     Abstract available
    
    
    
20. MISRA G, Grohman R, Kazachkov M, Nowak-Wegrzyn A, et al
    Severe asthma and new-onset meat allergy in a child-could a new puppy be to blame?
    Ann Allergy Asthma Immunol. 2025 Jul 2:S1081-1206(25)00338.
    PubMed    
    
    
    
21. JUBRAN J, Tam JS
    Identifying patients with uncontrolled asthma or severe asthma: Does terminology matter?
    Ann Allergy Asthma Immunol. 2025;135:13-14.
    PubMed    
    
    
    
22. NGO SY, Anderson WC 3rd
    Weighing real-world studies when choosing a biologic for asthma: Insights and pitfalls.
    Ann Allergy Asthma Immunol. 2025;135:11-12.
    PubMed    
    
    
    June 2025
23. YE Z, Harrar SW, Beyene J, Mersha TB, et al
    Incorporating Type-2 inflammation status with clinical diagnosis and transcriptomics data in asthma risk classification.
    Ann Allergy Asthma Immunol. 2025 Jun 26:S1081-1206(25)00321.
    PubMed     Abstract available
    
    
    
24. OMAR W, Hardy P, Pappalardo AA
    National Asthma Control Program: Funding Simple, Effective Strategies to Reduce Asthma Burden and Costs.
    Ann Allergy Asthma Immunol. 2025 Jun 22:S1081-1206(25)00319.
    PubMed    
    
    
    
25. PALLER AS, Soong W, Boguniewicz M, Geng B, et al
    Effect of tralokinumab on moderate-to-severe atopic dermatitis in patients with atopic comorbidities.
    Ann Allergy Asthma Immunol. 2025 Jun 22:S1081-1206(25)00315.
    PubMed     Abstract available
    
    
    
26. AYACHE M, Khalid F
    Increased Likelihood of COVID-19-Related Asthma Exacerbation with Higher Eosinophil Count.
    Ann Allergy Asthma Immunol. 2025 Jun 21:S1081-1206(25)00316.
    PubMed    
    
    
    
27. HAMADA Y, Thomas D, McDonald VM, Harvey ES, et al
    Impact of clinical remission on quality of life in severe eosinophilic asthma treated with mepolizumab.
    Ann Allergy Asthma Immunol. 2025 Jun 20:S1081-1206(25)00309.
    PubMed     Abstract available
    
    
    
28. RAYNER DG, Bakaa L, Hoyte F, Perry TT, et al
    Triple therapy versus dual inhaler therapy for moderate-to-severe asthma: an updated systematic review and meta-analysis.
    Ann Allergy Asthma Immunol. 2025 Jun 12:S1081-1206(25)00287.
    PubMed     Abstract available
    
    
    
29. HENAO MP, Malerich J, George DR
    Impact of Language Barriers on Pulmonary Function and Asthma Control.
    Ann Allergy Asthma Immunol. 2025 Jun 8:S1081-1206(25)00278.
    PubMed     Abstract available
    
    
    
30. WU Y, Xu W
    Refining asthma disparity research: A call for multidimensional assessment of Aspergillus fumigatus sensitization.
    Ann Allergy Asthma Immunol. 2025;134:739-740.
    PubMed    
    
    
    
31. SALMON MK, Arya P, Backer V, Aanaes K, et al
    Psychometric validation of the Standard Tests for Asthma, Allergic Rhinitis, and Chronic Rhinosinusitis in the United States.
    Ann Allergy Asthma Immunol. 2025;134:671-675.
    PubMed     Abstract available
    
    
    
32. HAN JK, Silver J, Dhangar I, Veeranki P, et al
    Quantifying corticosteroid burden in chronic rhinosinusitis with nasal polyps: A retrospective US database study.
    Ann Allergy Asthma Immunol. 2025;134:685-693.
    PubMed     Abstract available
    
    
    May 2025
33. HAZLITT R, Nguyen K, Wilson A, Clark P, et al
    Diversity, Equity, and Inclusion in Asthma Clinical Trials: A Cross-Sectional Analysis.
    Ann Allergy Asthma Immunol. 2025 May 27:S1081-1206(25)00267.
    PubMed     Abstract available
    
    
    
34. MA R, Zhang C, Zhang Y, Tan H, et al
    The Impact of Respiratory Syncytial Virus on Asthma Development and Exacerbation.
    Ann Allergy Asthma Immunol. 2025 May 17:S1081-1206(25)00236.
    PubMed     Abstract available
    
    
    
35. PUPPELS GJ, Hourihane JO, Nico C, Chaoimh CN, et al
    Erratum to 'Highly accurate, noninvasive early identification of infants with a filaggrin loss-of-function mutation by in vivo Raman spectroscopy, followed from birth to 12 months' [Annals of Allergy, Asthma & Immunology, 134;4 (2025) 457-464].
    Ann Allergy Asthma Immunol. 2025 May 17:S1081-1206(25)00220.
    PubMed    
    
    
    
36. KIM Y, Moonie S, Kim I, Yoo JW, et al
    Increasing trend in asthma hospitalization among cannabis-dependent abusers and recreational cannabis legalizations (1998-2021).
    Ann Allergy Asthma Immunol. 2025 May 11:S1081-1206(25)00232.
    PubMed    
    
    
    
37. DOWLING TC, Shah MM, Moulia DL, Hsu J, et al
    Recommended immunizations to reduce respiratory morbidity and mortality among US adults with asthma, by age.
    Ann Allergy Asthma Immunol. 2025;134:535-538.
    PubMed    
    
    
    
38. MURAI Y, Koya T, Koda H, Uji W, et al
    Dupilumab efficacy in relation to changes in club cell secretory protein 16.
    Ann Allergy Asthma Immunol. 2025;134:556-562.
    PubMed     Abstract available
    
    
    April 2025
39. NGUYEN VT, Roth K, Engelhardt E, Pearlstein A, et al
    The usual suspects: Respiratory Syncytial Virus and Rhinovirus drive asthma development and exacerbation.
    Ann Allergy Asthma Immunol. 2025 Apr 24:S1081-1206(25)00205.
    PubMed     Abstract available
    
    
    
40. SCOTT EA, Balasubramanian A, Brems JH, Wu TD, et al
    Peripheral eosinophil count as a biomarker for asthma exacerbation severity in acute care settings.
    Ann Allergy Asthma Immunol. 2025 Apr 18:S1081-1206(25)00183.
    PubMed     Abstract available
    
    
    
41. SCURLOCK AM, Fleischer DM, Toit GD, Arends NJT, et al
    Efficacy and Safety of Epicutaneous Immunotherapy in Peanut-allergic Children with Atopic Comorbidities.
    Ann Allergy Asthma Immunol. 2025 Apr 7:S1081-1206(25)00179.
    PubMed     Abstract available
    
    
    
42. GARDNER DD, Gokani R, Hey-Hadavi J, Williams D, et al
    Healthcare-Seeking Behaviors for Acute Asthma: A US Cross-sectional Survey.
    Ann Allergy Asthma Immunol. 2025 Apr 3:S1081-1206(25)00175.
    PubMed     Abstract available
    
    
    
43. GRAYSON MH
    Asthma and evolving trends in allergy and immunology.
    Ann Allergy Asthma Immunol. 2025;134:369.
    PubMed    
    
    
    March 2025
44. KALRA S, Kalra D, Nagaraja N, Hlaing WM, et al
    Food Allergy and Asthma in a Nationally Representative Sample of Adolescents in the United States.
    Ann Allergy Asthma Immunol. 2025 Mar 28:S1081-1206(25)00152.
    PubMed    
    
    
    
45. TO M, Arimoto Y, Honda N, Furusho N, et al
    Elevated oxidative stress and steroid insensitivity in patients with asthma and high body fat percentage.
    Ann Allergy Asthma Immunol. 2025 Mar 15:S1081-1206(25)00126.
    PubMed     Abstract available
    
    
    
46. FAN H, Ren Z, Zhang P, Zhou B, et al
    Increased asthma burden during and post the COVID-19 pandemic among U.S. adults.
    Ann Allergy Asthma Immunol. 2025 Mar 15:S1081-1206(25)00123.
    PubMed    
    
    
    
47. VIINANEN A, Ilmarinen P, Mehtala J, Jylhava J, et al
    Factors associated with the development of severe asthma - a nationwide study (FINASTHMA).
    Ann Allergy Asthma Immunol. 2025 Mar 9:S1081-1206(25)00119.
    PubMed     Abstract available
    
    
    
48. GELB AF, Tashkin DP
    Utility of using thoracic computed tomography to measure lung function decline and detect unsuspected emphysema in severe asthma.
    Ann Allergy Asthma Immunol. 2025;134:253-254.
    PubMed    
    
    
    
49. TANABE N
    Further evidence for the roles of computed tomography in managing severe asthma.
    Ann Allergy Asthma Immunol. 2025;134:251-252.
    PubMed    
    
    
    
50. MATHUR SK, Silver J, MacKnight SD, Urosevic A, et al
    Real-world mepolizumab treatment in eosinophilic granulomatosis with polyangiitis reduces disease burden in the United States.
    Ann Allergy Asthma Immunol. 2025;134:341-350.
    PubMed     Abstract available
    
    
    February 2025
51. LUGOGO NL, Gilbert IA, Gandhi HN, Tkacz JP, et al
    Exacerbation burden in patients treated as intermittent or mild-persistent asthma using short-acting beta(2)-agonist rescue.
    Ann Allergy Asthma Immunol. 2025 Feb 24:S1081-1206(25)00088.
    PubMed     Abstract available
    
    
    
52. SKEEN E, Hamlington KL, De Keyser H, Liu AH, et al
    Managing Childhood Asthma with an Eye Toward Environmental, Social and Behavioral Features.
    Ann Allergy Asthma Immunol. 2025 Feb 24:S1081-1206(25)00092.
    PubMed     Abstract available
    
    
    
53. CEGOLON L, Filon FL, Lange JH
    Social determinants of health, Black race, sensitization to indoor molds and risk of severe asthma.
    Ann Allergy Asthma Immunol. 2025;134:125-126.
    PubMed    
    
    
    
54. GALANT SP
    Oscillometry-determined small airway dysfunction as a significant risk for poor asthma control and exacerbations.
    Ann Allergy Asthma Immunol. 2025;134:123-124.
    PubMed    
    
    
    January 2025
55. BRUZZESE JM, Cespedes A, Ainapudi V, Kingston S, et al
    Barriers to Seeing a Healthcare Provider among Rural Adolescents with Poorly Controlled Asthma.
    Ann Allergy Asthma Immunol. 2025 Jan 25:S1081-1206(25)00046.
    PubMed    
    
    
    
56. GREIG R, Chan R, Fardon TC, Lipworth BJ, et al
    Real world effects of tezepelumab on small airways dysfunction in severe refectory asthma.
    Ann Allergy Asthma Immunol. 2025 Jan 25:S1081-1206(25)00064.
    PubMed    
    
    
    
57. COTTINI M, Ventura L, Lombardi C, Landi M, et al
    Small airway dysfunction mediates the relationship between FeNO and asthma control.
    Ann Allergy Asthma Immunol. 2025 Jan 16:S1081-1206(25)00004.
    PubMed     Abstract available
    
    
    
58. LEE JK, Pollard SJ, Liu MC, Schleich F, et al
    Mepolizumab real-world effectiveness in severe asthma with an eosinophilic phenotype and overlapping severe allergic asthma.
    Ann Allergy Asthma Immunol. 2025 Jan 11:S1081-1206(25)00003.
    PubMed     Abstract available
    
    
    
59. OPPENHEIMER J, Casale T
    Care of asthma-a rapidly moving story.
    Ann Allergy Asthma Immunol. 2025;134:1-2.
    PubMed    
    
    
    December 2024
60. MILIGKOS M, Oh J, Kwon R, Konstantinou GNu, et al
    Epidemiology of asthma across the ages.
    Ann Allergy Asthma Immunol. 2024 Dec 12:S1081-1206(24)01727.
    PubMed     Abstract available
    
    
    
61. ELLIOTT MR, O'Connor AE, Marshall GD
    Corrigendum to 'Inflammatory pathways in patients with post-acute sequelae of COVID-19' [Annals of Allergy, Asthma & Immunology 133/5 (2024) 507 - 515].
    Ann Allergy Asthma Immunol. 2024 Dec 7:S1081-1206(24)01716.
    PubMed    
    
    
    
62. OU MC, Tsai RY, Li CP, Gau SY, et al
    Real-world effectiveness of mepolizumab in patients with asthma and comorbid nasal polyps.
    Ann Allergy Asthma Immunol. 2024;133:732-733.
    PubMed    
    
    
    
63. CHAN R, Kuo CR, Fardon T, Thouseef MJ, et al
    The interplay between skeletal muscle adiposity and radiographic features of airway remodeling in persistent asthma.
    Ann Allergy Asthma Immunol. 2024;133:626-627.
    PubMed    
    
    
    November 2024
64. ZHANG B, Yan M, Li C, Zhao J, et al
    Impact of asthma severity on surgical outcomes in patients with chronic rhinosinusitis comorbid with asthma.
    Ann Allergy Asthma Immunol. 2024 Nov 29:S1081-1206(24)01712.
    PubMed     Abstract available
    
    
    
65. LANZ MJ, Chipps B, Zeiger RS, Bacharier LB, et al
    Pediatric Asthma Impairment and Risk Questionnaire: Rationale and Development of a Composite Control Tool.
    Ann Allergy Asthma Immunol. 2024 Nov 28:S1081-1206(24)01711.
    PubMed     Abstract available
    
    
    
66. CONWAY AE, Marshall GD, Oppenheimer J, Shaker MS, et al
    Should Biologics Be Available for All Patients with Uncontrolled Asthma, Regardless? Absolutely and Here's Why.
    Ann Allergy Asthma Immunol. 2024 Nov 28:S1081-1206(24)01713.
    PubMed    
    
    
    
67. GREIMANN E, Freigeh GE, Wettenstein RP, Nelson B, et al
    Mild Asthma- What Matters to Patients and Parents.
    Ann Allergy Asthma Immunol. 2024 Nov 26:S1081-1206(24)01708.
    PubMed     Abstract available
    
    
    
68. DUCHARME FM, Chan R
    Oscillometry in the diagnosis, assessment, and monitoring of asthma in children and adults: review article.
    Ann Allergy Asthma Immunol. 2024 Nov 25:S1081-1206(24)01702.
    PubMed     Abstract available
    
    
    
69. GOCHICOA-RANGEL L, Vargas MH
    How best to choose an oscillometer and reference equations for your patients with asthma.
    Ann Allergy Asthma Immunol. 2024 Nov 16:S1081-1206(24)01681.
    PubMed     Abstract available
    
    
    
70. COTTINI M, Lombardi C, Comberiati P, Berti A, et al
    Oscillometry-defined small airways dysfunction as a treatable trait in asthma.
    Ann Allergy Asthma Immunol. 2024 Nov 15:S1081-1206(24)01658.
    PubMed     Abstract available
    
    
    
71. ZHANG W, Li L, Zhang Y, Dai J, et al
    Perturbations in the airway microbiome are associated with type 2 asthma phenotype and severity.
    Ann Allergy Asthma Immunol. 2024 Nov 14:S1081-1206(24)01657.
    PubMed     Abstract available
    
    
    
72. LIEBERMAN JA, Chu DK, Ahmed T, Dribin TE, et al
    Corrigendum to <'A systematic review and expert Delphi Consensus recommendation on the use of vaccines in patients receiving dupilumab: A position paper of the American College of Allergy, Asthma and Immunology'> <[Annals of Allergy, Asthma & Immunolo
    Ann Allergy Asthma Immunol. 2024 Nov 2:S1081-1206(24)01630.
    PubMed    
    
    
    
73. YU JT, Gau SY, Li CP, Chang HC, et al
    Real-world association between cat ownership and asthma.
    Ann Allergy Asthma Immunol. 2024;133:613.
    PubMed    
    
    
    
74. SHEN CY, Li CP, Tsai RY, Chang HC, et al
    Infant urinary adrenal steroids and childhood asthma development.
    Ann Allergy Asthma Immunol. 2024;133:611-612.
    PubMed    
    
    
    
75. GRAYSON MH
    The future of allergy and immunology research: 2024 American College of Allergy, Asthma and Immunology Annals Fellow-in-Training award winners.
    Ann Allergy Asthma Immunol. 2024;133:505-506.
    PubMed    
    
    
    
76. ESCHENBACHER WH
    Treatment of type 2 inflammation: Targeted therapy for chronic rhinosinusitis with nasal polyps and asthma.
    Ann Allergy Asthma Immunol. 2024;133:497-498.
    PubMed    
    
    
    October 2024
77. RAO R, Han YY, Valentin-Rodriguez LA, Presto AA, et al
    Proximity to Fast-Food Restaurants and Pediatric Asthma Outcomes.
    Ann Allergy Asthma Immunol. 2024 Oct 26:S1081-1206(24)01631.
    PubMed    
    
    
    
78. RUPPRECHT C, Krishnaswamy G
    OSTEONECROSIS: A DISABLING DISEASE NOT TO BE IGNORED IN ASTHMA AND ATOPIC CONDITIONS.
    Ann Allergy Asthma Immunol. 2024 Oct 26:S1081-1206(24)01632.
    PubMed     Abstract available
    
    
    
79. GALLEGOS-KOYNER FJ, Hodo F, Barrera NI, Cerrud-Rodriguez RC, et al
    Opioid Use Disorder's Impact on Asthma Hospitalizations: A Propensity Matched Nationwide Study.
    Ann Allergy Asthma Immunol. 2024 Oct 18:S1081-1206(24)01577.
    PubMed     Abstract available
    
    
    
80. MANKA LA, Guntur VP, Stevens AD, Kolakowski C, et al
    The Supraglottic Index: An Indicator of Response to Laryngopharyngeal Reflux Therapy in Asthma.
    Ann Allergy Asthma Immunol. 2024 Oct 15:S1081-1206(24)01573.
    PubMed     Abstract available
    
    
    
81. ZIDAN E, Wilson G, Shin JJ, Chupp G, et al
    The Next Frontier: Defining and Optimizing Treatments for Patients with T2 Low Asthma.
    Ann Allergy Asthma Immunol. 2024 Oct 14:S1081-1206(24)01571.
    PubMed    
    
    
    
82. SELUK L, Davis AE, Rhoads S, Wechsler ME, et al
    Novel asthma treatments: Advancing Beyond Approved Novel Step-Up Therapies for Asthma.
    Ann Allergy Asthma Immunol. 2024 Oct 9:S1081-1206(24)01552.
    PubMed     Abstract available
    
    
    
83. MAILHOT-LAROUCHE S, Celis-Preciado C, Heaney LG, Couillard S, et al
    Identifying Super-Responders: a Review of the Road to Asthma Remission.
    Ann Allergy Asthma Immunol. 2024 Oct 7:S1081-1206(24)01559.
    PubMed     Abstract available
    
    
    
84. GREIG R, Stewart K, Chan R, Lipworth B, et al
    Assessment of bronchodilator responsiveness using low frequency impedance in type 2 high uncontrolled severe asthma.
    Ann Allergy Asthma Immunol. 2024 Oct 7:S1081-1206(24)01570.
    PubMed    
    
    
    
85. BUSSE WW
    The Role of Biologics in Inducing Remission in Asthma.
    Ann Allergy Asthma Immunol. 2024 Oct 7:S1081-1206(24)01557.
    PubMed     Abstract available
    
    
    
86. MIYATA Y, Tanaka A, Ebato T, Kashima A, et al
    Baseline forced oscillation technique predicting lack of exacerbations in adult with asthma: A 12-month prospective.
    Ann Allergy Asthma Immunol. 2024 Oct 4:S1081-1206(24)01553.
    PubMed     Abstract available
    
    
    
87. WEINBERGER MM, Hendeles L
    Biologics for asthma and comorbid nasal polyps.
    Ann Allergy Asthma Immunol. 2024;133:356-357.
    PubMed    
    
    
    
88. CORELLI ER, Peebles RS Jr
    Race toward more equitable pulmonary function testing?
    Ann Allergy Asthma Immunol. 2024;133:362-363.
    PubMed    
    
    
    
89. MCCULLOCH MR, Bothwell S, Brinton JT, Anderson WC 3rd, et al
    Effect of electronic medication monitoring on asthma outcomes in a multidisciplinary pediatric severe asthma clinic.
    Ann Allergy Asthma Immunol. 2024 Oct 1:S1081-1206(24)01533.
    PubMed    
    
    
    September 2024
90. BLOODWORTH MH, Staso PJ, Huang S, Farber-Eger E, et al
    Metabolic and weight components' impact on incident asthma using a real-world cohort.
    Ann Allergy Asthma Immunol. 2024 Sep 16:S1081-1206(24)01509.
    PubMed     Abstract available
    
    
    
91. CHAN R, Lipworth B
    Airway oscillometry in asthma - present and future perspectives.
    Ann Allergy Asthma Immunol. 2024 Sep 14:S1081-1206(24)01529.
    PubMed    
    
    
    
92. GLEESON PK, Morales KH, Kerlin MP, Fadugba OO, et al
    Asthma exacerbations in Aspergillus fumigatus-sensitized adults with asthma differs by race.
    Ann Allergy Asthma Immunol. 2024 Sep 9:S1081-1206(24)01504.
    PubMed     Abstract available
    
    
    
93. SIM DW, Choi S, Jeong J, Lee SY, et al
    Computed tomography-based measurements associated with rapid lung function decline in severe asthma.
    Ann Allergy Asthma Immunol. 2024 Sep 5:S1081-1206(24)01502.
    PubMed     Abstract available
    
    
    
94. KAIDASHEV I, Ditiatkovskaya E
    Managing Asthma and Allergies during the Russo-Ukrainian War.
    Ann Allergy Asthma Immunol. 2024 Sep 3:S1081-1206(24)00573.
    PubMed    
    
    
    
95. SHAMIM J
    The relationship of height and asthma.
    Ann Allergy Asthma Immunol. 2024;133:352.
    PubMed    
    
    
    
96. PHILIPENKO BS, Davis B, Cockcroft DW
    To stop or not to stop an asthma biologic, that is the question.
    Ann Allergy Asthma Immunol. 2024;133:236-237.
    PubMed    
    
    
    
97. BRIGHTLING CE, Caminati M, Llanos JP, Caveney S, et al
    Biomarkers and clinical outcomes after tezepelumab cessation: Extended follow-up from the 2-year DESTINATION study.
    Ann Allergy Asthma Immunol. 2024;133:310-317.
    PubMed     Abstract available
    
    
    August 2024
98. HAYASHI Y, Tanabe N, Shimizu K, Maetani T, et al
    Lower skeletal muscle density and airway structure on computed tomography in asthma (12/15 words).
    Ann Allergy Asthma Immunol. 2024 Aug 21:S1081-1206(24)00527.
    PubMed     Abstract available
    
    
    
99. HAGWOOD SR, Elliott M, Marshall GD
    Comparing Prevalence of Food Allergy in Exercise-induced Bronchoconstriction vs. Asthma.
    Ann Allergy Asthma Immunol. 2024 Aug 13:S1081-1206(24)00496.
    PubMed    
    
    
    
100. ROTBLAT D, Wei C, Reyna GC, Grabie Y, et al
     Impact of Cannabinoid Use on Acute Pulmonary Outcomes in Hospitalized Asthmatic Patients.
     Ann Allergy Asthma Immunol. 2024 Aug 3:S1081-1206(24)00486.
     PubMed    
     
     
     
101. MALDONADO-PUEBLA M, Ledford D, Cardet JC
     The minimal clinically important difference in the Asthma Impairment and Risk Questionnaire.
     Ann Allergy Asthma Immunol. 2024;133:123-124.
     PubMed    
     
     
     
102. STEWART K, Kuo CR, Chan R, Lipworth B, et al
     Evaluating an electronic device to monitor the type 2 high unified airway response to dupilumab.
     Ann Allergy Asthma Immunol. 2024;133:211-213.
     PubMed    
     
     
     July 2024
103. SOTO-RETES L, Milagro J, Crespo-Lessmann A, Curto E, et al
     Parasympathetic nervous system: a key role in control and mood disorders in patients with asthma.
     Ann Allergy Asthma Immunol. 2024 Jul 27:S1081-1206(24)00480.
     PubMed     Abstract available
     
     
     
104. FITZPATRICK AM, Mohammad AF, Desher K, Mutic AD, et al
     Clinical and inflammatory features of traffic-related diesel exposure in children with asthma.
     Ann Allergy Asthma Immunol. 2024 Jul 27:S1081-1206(24)00457.
     PubMed     Abstract available
     
     
     
105. HAN YY, Celedon JC
     The Effects of Violence and Related Stress on Asthma.
     Ann Allergy Asthma Immunol. 2024 Jul 26:S1081-1206(24)00479.
     PubMed     Abstract available
     
     
     
106. FRUEH L, Sharma R, Sheffield PE, Clougherty JE, et al
     Community Violence and Asthma: A Review.
     Ann Allergy Asthma Immunol. 2024 Jul 20:S1081-1206(24)00453.
     PubMed     Abstract available
     
     
     
107. CHIARELLA SE, Garcia-Guaqueta DP, Drake LY, Dixon RE, et al
     Sex differences in sociodemographic, clinical, and laboratory variables in childhood asthma: A birth cohort study.
     Ann Allergy Asthma Immunol. 2024 Jul 15:S1081-1206(24)00426.
     PubMed     Abstract available
     
     
     
108. TAJIRI T, Suzuki M, Nishiyama H, Ozawa Y, et al
     Efficacy of dupilumab for severe chronic rhinosinusitis with nasal polyps and asthma: A prospective study.
     Ann Allergy Asthma Immunol. 2024 Jul 5:S1081-1206(24)00422.
     PubMed     Abstract available
     
     
     
109. BERNSTEIN JA, Silver J, Packnett E, Lew CR, et al
     Real-world unified airway benefits of mepolizumab: effectiveness in patients with asthma and comorbid nasal polyps.
     Ann Allergy Asthma Immunol. 2024 Jul 5:S1081-1206(24)00421.
     PubMed     Abstract available
     
     
     
110. SIM S, Jang JH, Park HS
     Contribution of non-neuronal cholinergic system to T2-low airway inflammation in severe asthma.
     Ann Allergy Asthma Immunol. 2024;133:7-8.
     PubMed    
     
     
     
111. GUTIERREZ CG, Bukstein DA
     Functionality of the Asthma Impairment and Risk Questionnaire and its implications in shared decision-making.
     Ann Allergy Asthma Immunol. 2024;133:5-6.
     PubMed    
     
     
     
112. HARRIS D, Borish L
     How we treat type 2 low asthma.
     Ann Allergy Asthma Immunol. 2024;133:43-46.
     PubMed    
     
     
     
113. MULLUR J, Buchheit KM
     Correction to "Aspirin-exacerbated respiratory disease" by Mullur J and Buchheit KM (Ann Allergy Asthma Immunol 131 (2023) 317-324).
     Ann Allergy Asthma Immunol. 2024;133:118.
     PubMed    
     
     
     
114. CONWAY AE, White AA, Borish L, Shaker M, et al
     Eicosanoids, innate immunity, and alarmins in aspirin-exacerbated respiratory disease.
     Ann Allergy Asthma Immunol. 2024;133:13-15.
     PubMed    
     
     
     June 2024
115. TRASANDE L
     The Role of Plastics in Allergy, Immunology and Human Health: What the Clinician Needs to Know and Can Do About It.
     Ann Allergy Asthma Immunol. 2024 Jun 28:S1081-1206(24)00417.
     PubMed     Abstract available
     
     
     
116. ADELEKE S, Ongtengco A, Youssef C, Hardy P, et al
     Addressing Critical Barriers for Sustainability of Asthma Stock Inhaler Policy Implementation and Resultant Programming.
     Ann Allergy Asthma Immunol. 2024 Jun 26:S1081-1206(24)00373.
     PubMed     Abstract available
     
     
     
117. BAREILLE P, Forth R, Imber V, Bondarenko I, et al
     Once-Daily Fluticasone Furoate/Vilanterol Versus Once-Daily Fluticasone Furoate in Asthma Patients Aged 5-17 Years.
     Ann Allergy Asthma Immunol. 2024 Jun 25:S1081-1206(24)00376.
     PubMed     Abstract available
     
     
     
118. MISHRA PE, Han YY, Hill K, Rosser FJ, et al
     Persistent cat ownership and asthma in a longitudinal study of Puerto Rican youth.
     Ann Allergy Asthma Immunol. 2024 Jun 24:S1081-1206(24)00375.
     PubMed     Abstract available
     
     
     
119. ZAEH SE, Zimmerman ZE, Eakin MN, Chupp G, et al
     Adoption and Implementation of Maintenance and Reliever Therapy for Adults with Moderate to Severe Asthma.
     Ann Allergy Asthma Immunol. 2024 Jun 17:S1081-1206(24)00363.
     PubMed     Abstract available
     
     
     
120. ZEIGER JS, Silvers WS, Zeiger RS
     Comparison of Cannabis Knowledge, Attitudes, and Practice (KAP) between Allergists and Allergic and Asthmatic Patients.
     Ann Allergy Asthma Immunol. 2024 Jun 13:S1081-1206(24)00347.
     PubMed    
     
     
     
121. LIEBERMAN JA, Chu DK, Ahmed T, Dribin TE, et al
     Use of Vaccines in Patients Receiving Dupilumab, A Systematic Review and Expert Delphi Consensus Recommendation: A position paper of the American College of Allergy, Asthma and Immunology.
     Ann Allergy Asthma Immunol. 2024 Jun 5:S1081-1206(24)00337.
     PubMed     Abstract available
     
     
     
122. SEDAGHAT AR, Phillips KM
     Unifying the airway through multiomics.
     Ann Allergy Asthma Immunol. 2024;132:667-668.
     PubMed    
     
     
     May 2024
123. BELLANTI JA, Settipane RA
     Legacy of Congressman George Miller O'Brien: Advocate for the patient with asthma and allergic disease.
     Ann Allergy Asthma Immunol. 2024 May 31:S1081-1206(24)00308.
     PubMed    
     
     
     
124. PETERSEN M, Bingemann TA
     Correction to "Navigating allergic disease in military accessions: A crucial role for civilian allergists" (Ann Allergy Asthma Immunol 132 (2024) 547-548).
     Ann Allergy Asthma Immunol. 2024 May 18:S1081-1206(24)00285.
     PubMed    
     
     
     
125. CHUPP G, Murphy KR, Gandhi HN, Gilbert I, et al
     Asthma control in the United States: relationships between short-acting beta(2)-agonist and systemic corticosteroid use.
     Ann Allergy Asthma Immunol. 2024 May 11:S1081-1206(24)00287.
     PubMed     Abstract available
     
     
     
126. KLOEPFER KM, Kennedy JL
     Decoding viral infections and risk for asthma: Biomarkers or clinical histories?
     Ann Allergy Asthma Immunol. 2024;132:553-554.
     PubMed    
     
     
     
127. KATIAL RK, Hoyte FCL
     Comment on geographic variation in disease burden among patients with severe persistent asthma in the United States.
     Ann Allergy Asthma Immunol. 2024;132:551-552.
     PubMed    
     
     
     April 2024
128. TURI KN, Li Y, Xu Y, Gebretsadik T, et al
     The Association of Infant Urinary Adrenal Steroids with the Risk of Childhood Asthma Development.
     Ann Allergy Asthma Immunol. 2024 Apr 15:S1081-1206(24)00215.
     PubMed     Abstract available
     
     
     
129. WOO SD, Park HS, Yang EM, Ban GY, et al
     8-Iso-prostaglandin F2alpha as a biomarker of T2-low airway inflammation and remodeling in adult asthma.
     Ann Allergy Asthma Immunol. 2024 Apr 12:S1081-1206(24)00214.
     PubMed     Abstract available
     
     
     March 2024
130. MOTA D, Martins C, Puga N, Moreira A, et al
     Asthma and allergy screening in elite football athletes: is it worth it?
     Ann Allergy Asthma Immunol. 2024 Mar 29:S1081-1206(24)00205.
     PubMed    
     
     
     
131. LEE PH, An M, Hwang D, Jang AS, et al
     Impact of circulating angiomotin and angiostatin on clinical variables in patients with asthma.
     Ann Allergy Asthma Immunol. 2024 Mar 29:S1081-1206(24)00207.
     PubMed    
     
     
     
132. HUANG D, Zhang L, Liu Y, Wang J, et al
     Activated non-neuronal cholinergic system correlates with non-type 2 inflammation and exacerbations in severe asthma.
     Ann Allergy Asthma Immunol. 2024 Mar 16:S1081-1206(24)00150.
     PubMed     Abstract available
     
     
     
133. ZAHRAEI HN, Schleich F, Louis G, Gerday S, et al
     Evidence for two clusters among non-eosinophilic asthmatics.
     Ann Allergy Asthma Immunol. 2024 Mar 16:S1081-1206(24)00154.
     PubMed     Abstract available
     
     
     
134. CHIPPS BE, Zeiger RS, Beuther DA, Wise RA, et al
     Advancing assessment of asthma control with a composite tool: the Asthma Impairment and Risk Questionnaire.
     Ann Allergy Asthma Immunol. 2024 Mar 15:S1081-1206(24)00153.
     PubMed     Abstract available
     
     
     
135. LI Y, Hong X, Chandran A, Keet CA, et al
     Associations between cord blood acetaminophen biomarkers and childhood asthma with and without allergic comorbidities.
     Ann Allergy Asthma Immunol. 2024 Mar 12:S1081-1206(24)00143.
     PubMed     Abstract available
     
     
     
136. GWAK DY, Tea JC, Fatima FN, Palka JM, et al
     Contribution of caregiver and child anxiety and depressive symptoms to child asthma-related quality of life.
     Ann Allergy Asthma Immunol. 2024 Mar 6:S1081-1206(24)00141.
     PubMed     Abstract available
     
     
     February 2024
137. CETIN GP, Yilmaz I
     What should be the outcome of biological treatment in asthma: "Remission on Treatment" or "Super-responder".
     Ann Allergy Asthma Immunol. 2024 Feb 23:S1081-1206(24)00103.
     PubMed    
     
     
     
138. CHAN R, Duraikannu C, Thouseef MJ, Lipworth B, et al
     Lower paraspinal muscle density is associated with small airway dysfunction in women with persistent asthma.
     Ann Allergy Asthma Immunol. 2024 Feb 22:S1081-1206(24)00089.
     PubMed    
     
     
     January 2024
139. CHEN C, Song X, Murdock DJ, Marcus A, et al
     Association between allergic conditions and COVID-19 susceptibility and outcomes.
     Ann Allergy Asthma Immunol. 2024 Jan 17:S1081-1206(24)00011.
     PubMed     Abstract available
     
     
     November 2023
140. KIM BE, Hui-Beckman JW, Nevid MZ, Goleva E, et al
     Air pollutants contribute to epithelial barrier dysfunction and allergic diseases.
     Ann Allergy Asthma Immunol. 2023 Nov 23:S1081-1206(23)01462.
     PubMed     Abstract available
     
     
     
141. GEVAERT P, Mullol J, Saenz R, Ko J, et al
     Omalizumab improves sinonasal outcomes in patients with chronic rhinosinusitis with nasal polyps regardless of allergic status.
     Ann Allergy Asthma Immunol. 2023 Nov 9:S1081-1206(23)01393.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Asthma is free of charge.